ATE386716T1 - Biphenylderivate - Google Patents

Biphenylderivate

Info

Publication number
ATE386716T1
ATE386716T1 AT01272246T AT01272246T ATE386716T1 AT E386716 T1 ATE386716 T1 AT E386716T1 AT 01272246 T AT01272246 T AT 01272246T AT 01272246 T AT01272246 T AT 01272246T AT E386716 T1 ATE386716 T1 AT E386716T1
Authority
AT
Austria
Prior art keywords
group
acat
substituted
aromatic hydrocarbon
unsubstituted aromatic
Prior art date
Application number
AT01272246T
Other languages
English (en)
Inventor
Takayuki Namiki
Kenichi Kishii
Masaki Mitani
Masashi Tamai
Naoki Hiyama
Makoto Kimura
Satoshi Ichinomiya
Original Assignee
Pola Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc filed Critical Pola Pharma Inc
Application granted granted Critical
Publication of ATE386716T1 publication Critical patent/ATE386716T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01272246T 2000-12-26 2001-12-05 Biphenylderivate ATE386716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000394372 2000-12-26

Publications (1)

Publication Number Publication Date
ATE386716T1 true ATE386716T1 (de) 2008-03-15

Family

ID=18860013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01272246T ATE386716T1 (de) 2000-12-26 2001-12-05 Biphenylderivate

Country Status (7)

Country Link
US (1) US7531576B2 (de)
EP (1) EP1354871B1 (de)
JP (1) JP4035444B2 (de)
AT (1) ATE386716T1 (de)
CA (1) CA2434228C (de)
DE (1) DE60132920T2 (de)
WO (1) WO2002051799A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2321011A1 (de) * 2008-06-25 2011-05-18 Pfizer Inc. Diaryl-verbindungen und ihre verwendungen
HK1257569A1 (zh) 2016-02-16 2019-10-25 The University Of Queensland 磺醯脲和相关化合物及其用途
CN112672995A (zh) * 2018-08-15 2021-04-16 英夫拉索姆有限公司 新型磺酰胺脲化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8805628D0 (en) * 1988-03-09 1988-04-07 Erba Farmitalia Hypolipidaemic imidazol-2-yl-derivatives of bicyclic compounds & process for their preparation
GB8907656D0 (en) * 1989-04-05 1989-05-17 May & Baker Ltd New compositions of matter
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
DE122010000024I1 (de) 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
US5143919A (en) * 1990-08-17 1992-09-01 Takeda Chemical Industries, Ltd. Thienopyridine derivatives and their pharmaceutical use
US5362878A (en) * 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
DK0600950T3 (da) * 1991-08-22 1997-04-21 Warner Lambert Co Tetrazolamider som inhibitorer af ACAT
JPH05320143A (ja) * 1992-03-18 1993-12-03 Mochida Pharmaceut Co Ltd 新規ピリミジン誘導体
US5312820A (en) * 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
JP3116256B2 (ja) * 1993-01-14 2000-12-11 小野薬品工業株式会社 (チオ)ウレア誘導体
JPH0748360A (ja) 1993-05-31 1995-02-21 Yoshitomi Pharmaceut Ind Ltd ビフェニルテトラゾール誘導体
AU3577995A (en) 1994-10-04 1996-04-26 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
WO1999012534A1 (en) 1997-09-10 1999-03-18 Ono Pharmaceutical Co., Ltd. Peroxisome proliferator-activated receptor controllers

Also Published As

Publication number Publication date
DE60132920T2 (de) 2009-02-12
DE60132920D1 (de) 2008-04-03
JPWO2002051799A1 (ja) 2004-04-22
CA2434228A1 (en) 2002-07-04
EP1354871A4 (de) 2005-10-26
JP4035444B2 (ja) 2008-01-23
US20040048909A1 (en) 2004-03-11
US7531576B2 (en) 2009-05-12
CA2434228C (en) 2009-08-04
EP1354871A1 (de) 2003-10-22
EP1354871B1 (de) 2008-02-20
WO2002051799A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
DK0656887T3 (da) Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
ATE273305T1 (de) Thrombin-inhibitoren
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
FI862210A0 (fi) Imidazoheterocykliska foereningar och foerfarande foer deras framstaellning.
DE60232739D1 (de) Aktivator des peroxisomproliferator-aktivierten rezeptors delta
NO20023457L (no) Nye piperidinforbindelser og legemidler inneholdende de samme
ATE331715T1 (de) Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
BR1100756KB1 (pt) droga profilática ou terapêutica para nefropatia ou nefrite glomerular.
DE69921151D1 (de) Fluorszierende marker
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
NZ302072A (en) 1,3-diamino propyl stereomeric derivatives and organic acid and inorganic salts of their amine intermediates in the preparation of retroviral protease inhibitors
PT90725A (pt) Processo para a preparacao de novos compostos cefem
DE60132920D1 (de) Biphenylderivate
PT1234818E (pt) Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem
BR0002287A (pt) Compostos de piridina ou piperidina substituìdas, processo para preparação deles e composições farmacêuticas contendo-os
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
WO2001051004A3 (en) Anti-cancer agent containing naphthoquinone compound
DK0469833T3 (da) N-benzylindoler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende dem
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
TW375525B (en) Inhibitors for morphine-like drug induced emesis containing active components (R)-1-ethyl-4-methyl hexahydro-1H-1,4-diazepine derivatives
DK0656362T3 (da) Makrocykliske forbindelser og deres anvendelse som farmaceutiske præparater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties